CRP and polycystic ovary syndrome: As expected, MUO-PCOS patients presented both worse endocrine and metabolic profiles, with higher levels of testosterone, higher values of Ferriman-Gallwey score and of HoMA-IR, and higher levels of hs-CRP, as compared to their MHO-counterpart.